Countries citing papers authored by Hamblin Phillips
Since
Specialization
Citations
This map shows the geographic impact of Hamblin Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamblin Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamblin Phillips more than expected).
Fields of papers citing papers by Hamblin Phillips
This network shows the impact of papers produced by Hamblin Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamblin Phillips. The network helps show where Hamblin Phillips may publish in the future.
Co-authorship network of co-authors of Hamblin Phillips
This figure shows the co-authorship network connecting the top 25 collaborators of Hamblin Phillips.
A scholar is included among the top collaborators of Hamblin Phillips based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Hamblin Phillips. Hamblin Phillips is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Talmadge, James E., et al.. (1988). Immunomodulatory properties of recombinant murine and human tumor necrosis factor.. PubMed. 48(3). 544–50.119 indexed citations
6.
Talmadge, James E., Henry R. Tribble, Robin Pennington, Hamblin Phillips, & Robert H. Wiltrout. (1987). Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.. PubMed. 47(10). 2563–70.110 indexed citations
7.
Talmadge, James E., Hamblin Phillips, John Schindler, Henry R. Tribble, & Robin Pennington. (1987). Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.. PubMed. 47(21). 5725–32.81 indexed citations
8.
Talmadge, James E., Paul L. Black, Henry R. Tribble, et al.. (1987). Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2.. PubMed. 13(6). 327–37.14 indexed citations
Talmadge, James E., Barbara Lenz, Robin Pennington, et al.. (1986). Immunomodulatory and therapeutic properties of bestatin in mice.. PubMed. 46(9). 4505–10.74 indexed citations
11.
Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.. PubMed. 45(3). 1058–65.42 indexed citations
12.
Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.. PubMed. 45(3). 1066–72.27 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.